Clinical Trial to Evaluate the Efficacy of Bifidobacterium BB-12® in the Treatment of Infantile Colic

NCT03434249 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Infantile Colic
Colic, Infantile

Interventions

DIETARY_SUPPLEMENT: Bifidobacterium, BB-12® (Bifidolactis Infant)
DIETARY_SUPPLEMENT: Bifidolactis Infant Placebo

Sponsor

SOFAR S.p.A.